Biomedicines Events Announce Your Event Here

No upcoming events

20–22 September 2017 The 8th World ADC San Diego

San Diego, CA, USA

Now in it’s 8th year, World ADC San Diego is the industry’s definitive ADC conference. It’s mission – to be the environment in which scientists can communicate problems and solutions; share novel data and forge networks to develop more clinically impactful ADCs.

Over 3 full days, this multi-tracked conference will address every element of ADC research from early discovery to marketization making it the most comprehensive antibody drug conjugate forum you’ll attend this year.

Join your peers and 81 industry expert speakers at this year’s conference.

21–22 September 2017 Global Precision Medicine & Biomarkers Leaders Summit

Munich, Germany

The Precision Medicine and Biomarkers Leaders Summit will provide a forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.

More intimate roundtable discussions will also provide an opportunity for you and your peers to cover, in detail, issues such as fulfilling the potential of big data, conducting precision medicine clinical trials and advancing liquid biopsies to the clinic.

22–23 September 2017 Aptamers in Bordeaux

Bordeaux, France

Aptamers in Bordeaux is an international conference on Aptamer Biology, Chemistry and Technologies. The meeting will take place in Bordeaux on September 22-23 2017, just before the 13th annual meeting the Oligonucleotide Therapeutics Society (OTS 2017).

25 September 2017 The Road from Nanomedicine to Precision Medicine - 15th Annual International Conference


Join us for this free international conference that explores recent advances in medicine, biotech and pharma. There will be free lunch provided as well as a raffle contest.

There is no registration required to attend.

13–14 November 2017 Superbugs & Superdrugs USA

Iselin, New Jersey, USA

Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017.

Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates.

As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.

For further information visit or contact the team on Tel: +44 (0)20 7827 6000 / Email:

15–18 March 2018 AAT-AD/PDTM​ 2018

Torino, Italy

The AAT-AD/PDTM Focus Meeting 2018 in Torino is a new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (AAT) and AD/PDTM. This Alzheimer’s disease conference and Parkinson’s disease conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in
Alzheimer’s, Parkinson’s and other related neurological disorders. AAT-AD/PDTM 2018 will further advance innovative strategies in order to focus on driving successful collaborations among academia and industry.

19–20 March 2018 Superbugs & Superdrugs 2018

London, United Kingdom

SMi Group is thrilled to announce the 20th Annual Superbugs & Superdrugs Conference in London on 19th – 20th March 2018. As the global threat of antimicrobial resistance continues to develop, it is clear that a global commitment is required in order to tackle the ever-increasing problem of multidrug-resistant bacteria.

This year’s event will gather leaders from pharmaceutical companies, academia and the wider scientific community together with regulatory agencies and public-private partnerships, to discuss the growing threat of antibiotic resistance.

Join us to learn about various strategies in place to support antimicrobial resistance research & development, evaluate the latest scientific advancements for tackling antimicrobial resistance and consider potential novel candidates and alternatives to anti-microbials.

The event will also focus on the strategies pharmaceutical companies use to assist the development of new therapeutics & drugs, how to obtain funding for new projects and address why there is a current lack of incentives for researchers working in antimicrobial resistance research and development.

16–17 April 2018 5th Annual Biosimilars & Biobetters Congress

London, UK

Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.

Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics

Two-day interactive conference addressing the following topics:
Market Access Strategies, Opportunities, Clinical Development and Commercial Challenges
Developing Biosimilars and Biobetters – Manufacturing and Bio-analytics

Free Pre-Congress Live Webinars

Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT

Register today for free:

Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT

Register today for free:

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact

View Agenda here:

17–19 June 2018 20th Symposium on Infections in the Immunocompromised Host

Athens, Greece

We encourage all who are interested in the clinical practice and research on infections in immunocompromised host to attend the 20th ICHS Symposium in Athens, Greece June 17-19, 2018. Many symposia, plenary sessions, poster sessions will provide the attendee with opportunities to meet with outstanding leaders and clinical experts in the broad field of infectious diseases and immune-deficiencies while covering such diverse topics as new diagnostics,  infections in transplant recipients,  invasive fungal infections and resistance,  treatment of multi-resistant bacteria, infectious complications in immunocompromised children,  life-threatening infections and intensive care in neutropenic cancer patients ,antiviral and antifungal immune responses in compromised hosts,  prophylaxis and treatment of viral infections in immunocompromised hosts, and others.

28–29 June 2018 RNA Therapeutics: From Base Pairs to Bedsides

UMass Medical School, Worcester, MA, USA

We live in an exciting time for the RNA research community. Throughout the latter half of the 20th century, we believed that RNA’s primary role was to intermediate between DNA and protein. Over the last three decades, those long-held beliefs have been shattered. From ncRNAs to RNAi, from CRISPR to circular RNAs, we have witnessed astonishing discoveries and equally amazing translation of these breakthroughs to therapy. Come and join the discussion as we explore the era of RNA therapeutics during our inaugural conference at the RNA Therapeutics Institute.

8–10 October 2018 4th European NF-kB subunit meeting

Grasse, French Riviera

The ethos of the workshop is to bring together researchers interested in the biology of the NF-kB subunits from all over Europe (and sometimes beyond) in an informal and relaxed setting to present and discuss unpublished work from their laboratories. We encourage talks from scientists at all stages of their careers and our aim is to provide an opportunity for as many as possible of those who wish to present their data to be able to do so.
The subject areas covered at the workshops are diverse. These include fundamental mechanistic studies of the NF-kB proteins function as transcription factors, including proteomic analysis of subunit post-translational modifications and genome wide analysis of genetic targets through ChIP Seq and RNA Seq analysis. Another focus of the workshops is the physiological and pathological roles of the NF-kB subunits. Data presented includes those using mice and other model systems, together with analysis of normal and diseased human tissues. We have sessions devoted to the role of NF-kB in the immune and inflammatory responses as well as its role in cancer.

The meeting will be held in Grasse, considered the world’s capital of perfume and was made town of art and history. The venue “Village Vacances les Cèdres” is located at 800m from Grasse downtown in the heart of a tree and flower park of 2,5 ha, a favorable framework for scientific exchange and sharing. The venue is near the international airport of Nice (south east of France), and a shuttle service will be organized to drive you to the workshop.

This is a very special occasion for us to meet and discuss and we hope that many of you will attend the conference and share this great scientific time gathering the European NF-kB community.

We look forward to seeing you in France!

4–6 November 2018 2018 NCRI Cancer Conference

Scottish Event Campus, Glasgow, UK

The NCRI Cancer Conference is the UK’s largest forum showcasing the latest advances in cancer research. The Conference provides a platform for researchers, clinicians, people affected by cancer and industry representatives to come together to discuss, present and showcase high-quality research. Informative and interactive educational sessions attract over 1,500 delegates each year and create the ideal setting to establish new collaborations with key stakeholders in cancer research.

11–13 November 2013 9th Annual European Antibody Congress 2013

Geneva, Switzerland

The 9th European Antibody Congress is a content packed, 2 day event with 3 tracks. 

The 3 tracks cover strategies and opportunities from mAb research, mAb production, ADCs and Biosimilars. 

Delegates can experience and attend only those sessions most relevant to them. 

Meet the full value chain of industry executives, middle managers, public health professionals, key influencers and end-users

29–31 March 2015 EMBL Symposium: Frontiers in Stem Cells & Cancer

Heidelberg, Germany


  • Stem cells in cancer
  • Stem cells, cancer & metastasis
  • Stem cell aging & metabolism
  • Non-coding RNAs in stem cells
  • Epigenetics and cancer genomics

14–18 July 2015 ICMI 2015 - 17th International Congress of Mucosal Immunology

Berlin, Germany


  • Biology of innate and adaptive immune responses at mucosal surfaces
  • The host-microbiota interface
  • Impact of the microbiota on systemic immunity
  • Mucosal immunity in humans
  • Translational immunology in inflammatory bowel disease
  • Mechanisms of antigen uptake
  • Regulation of immunity in the intestine, lung and UG tract

3–4 September 2015 Cancer diagnosis and Therapy Congress

London, UK

The two day program will address key concerns such as cancer Immunotherapy, molecular targeted therapy, metabolomics in cancer tumour assessments & profiling, nanotechnology in cancer therapy, hormone therapy, stem cell Transplantation, surgical oncology, epigenetics, cancer genomics, cancer biomarkers, bio banking, non-invasive cancer diagnostics, organ specific cancers, cancer epidemiology and clinical trial in cancer research.

19–22 October 2015 Stem Cells: From Basic Biology to Disease Therapies

Suzhou, China

The International Society for Stem Cell Research (ISSCR) together with the Cold Spring Harbor Asia (CSHA) present Stem Cells: From Basic Biology to Disease Therapies International Symposium. The International Symposia series expands the global reach of ISSCR and CSHA educational programming and invites attendees from around the world.

Stem Cells: From Basic Biology to Disease Therapies will highlight the latest directions of stem cell research, including new techniques in genome editing, that are moving the field to new understandings of disease and toward therapeutic applications. Hear from leaders in pluripotent stem cell biology, stem cells of the mesoderm and endoderm lineages, and in driving stem-cell based products into clinical trials.

28–29 October 2015 Big Data in Health Care Conference

Munsbach, Luxembourg

The main objective of the Symposium is to bring together worldwide experts from academia, industry, doctors, policy makers and patient organisations in the field of Big data in Health Care to exchange about state-of-the-art research and technologies. The aim is to critically review the current scientific knowledge and the entire life cycle of Big Data in Health Care.

The conference will take place from 28 to 29 October 2015 in the Hôtel Légère, Luxembourg-Munsbach.

25–27 April 2016 Stem Cell Summit 2016

Boston, MA, USA

GTCbio's Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells.

26–27 April 2016 5th Stem Cell Product Development & Commercialization Conference

Boston, MA, USA

This forum presents cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, funding, regulations, manufacturing, product development, and the business of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be discussed.

1–3 June 2016 Infectious Diseases World Summit

San Diego, CA, USA

This Summit seeks to highlight all stages of the field, from research and novel therapeutics, to commercialization aspects and market activity. Colleagues from academia, industry, and government will gather at the interface of infectious diseases drug development to address current issues and find solutions to move the field forward into the future.

12–13 July 2016 Extracellular Vesicles 2016

Cambridge. UK

Clarifying contradictions in the characterization and isolation of extracellular vesicles, and identifying where the most promising opportunities for therapeutics and diagnostics lie, is proving to be one of the most attractive challenges of the decade for the global biomedical community

1–2 November 2016 Cancer Immunotherapy & Biofluid Biopsies 2016

Boston, USA

Cancer Immunotherapy & Biofluid Biopsies 2016 brings together the key opinion leaders in the immunotherapy and tumor immunology fields to address the most up-to-date strategies for immune therapy and means by which immunotherapies may be rationally-combined with more traditional anti-cancer therapeutics. This field is converging with biofluid biopsies/liquid biopsies and therefore this conference brings together these two disciplines as they are co-evolving.

Back to Top